Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

Sponsor
Université Catholique de Louvain
Study ID
NCT07000916
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
2 Years - 50 Years
Healthy Volunteers
Not accepted

Study Details

Population: Juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA) and seronegative / psoriatic / undifferentiated arthritis (UA), systemic lupus erythematosus (SLE) or diffuse systemic sclerosis dSS). Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA. These 5 cohorts will be subject to standardized clinical monitoring.

Key Dates

First listed
Jun 3, 2025
Start date
Sep 11, 2013
Status verified
May 2025
Primary completion
Mar 31, 2028
Completion
Mar 31, 2028

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: juvenile idiopathic arthritis (JIA)
    aged \<= 16 y.o. recent diagnosis of JIA and DMARDs treatment-naive patients; aged \<18 y.o. recent diagnosis of JIA
  • Arm: rheumatoid arthritis (RA)
    aged =\>18; =\< 50 y.o. recent diagnosis of RA and DMARDs treatment-naive patients
  • Arm: diffuse systemic sclerosis (dSS)
    aged =\>18; =\< 50 y.o. recent diagnosis of dSS and DMARDs treatment-naive patients
  • Arm: seronegative arthritis (UA)
    aged =\>18; =\< 50 y.o. recent diagnosis of UA and DMARDs treatment-naive patients
  • Arm: systemic lupus erythematosus (SLE)
    aged =\>18; =\< 50 y.o. recent diagnosis of SLE and DMARDs treatment-naive patients

Primary Outcome Measure

Remission rate or absence of synovitis in Rheumatoid arthritis patients [ Time Frame: Through the entire study, during approximately 15 years ]

Central Contacts

Find similar trials

Nationwide
Psoriatic arthritis trialsRheumatoid arthritis trialsLupus (SLE) trialsRheumatology trialsAutoimmune disease trialsMusculoskeletal disorders trials

Related Studies